Centene Corporation $CNC Shares Acquired by Pallas Capital Advisors LLC

Pallas Capital Advisors LLC increased its position in shares of Centene Corporation (NYSE:CNCFree Report) by 126.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 146,439 shares of the company’s stock after acquiring an additional 81,749 shares during the period. Pallas Capital Advisors LLC’s holdings in Centene were worth $6,026,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Addison Advisors LLC increased its stake in Centene by 455.6% during the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after purchasing an additional 606 shares during the period. Mowery & Schoenfeld Wealth Management LLC purchased a new position in shares of Centene in the third quarter valued at approximately $27,000. WPG Advisers LLC grew its holdings in shares of Centene by 44.5% in the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after purchasing an additional 282 shares in the last quarter. Bogart Wealth LLC increased its stake in Centene by 11,011.1% during the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after buying an additional 991 shares during the period. Finally, Ameriflex Group Inc. lifted its holdings in Centene by 152.5% during the 3rd quarter. Ameriflex Group Inc. now owns 1,010 shares of the company’s stock worth $36,000 after buying an additional 610 shares in the last quarter. 93.63% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Sanford C. Bernstein restated an “outperform” rating and issued a $59.00 price target on shares of Centene in a research note on Tuesday, January 6th. TD Cowen increased their price objective on Centene from $34.00 to $38.00 and gave the company a “hold” rating in a research note on Wednesday, February 11th. Wells Fargo & Company set a $44.00 target price on Centene and gave the stock an “equal weight” rating in a research note on Wednesday, February 18th. Argus upgraded Centene to a “hold” rating in a report on Monday, February 9th. Finally, Robert W. Baird increased their price target on Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Three research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $41.81.

Check Out Our Latest Report on CNC

Centene Stock Performance

Shares of CNC stock opened at $32.00 on Friday. The company has a market cap of $15.74 billion, a P/E ratio of -2.35, a PEG ratio of 0.74 and a beta of 0.48. The firm has a fifty day moving average price of $40.39 and a 200 day moving average price of $38.67. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.87. Centene Corporation has a 12 month low of $25.08 and a 12 month high of $66.03.

Centene (NYSE:CNCGet Free Report) last announced its quarterly earnings results on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.22) by $0.03. The company had revenue of $49.73 billion during the quarter, compared to the consensus estimate of $48.41 billion. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.Centene’s revenue for the quarter was up 21.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Sell-side analysts predict that Centene Corporation will post 6.86 earnings per share for the current fiscal year.

Centene Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

See Also

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.